Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
IOL Chemicals And Pharmaceuticals Ltd.
Change Company   
BSE Code 524164
ISIN Demat INE485C01029
Book Value 57.49
NSE Code IOLCP
Dividend Yield % 0.00
Market Cap 28460.43
P/E 28.18
EPS 3.44
Face Value 2  
16-Jun-2025 IOL Chemicals registers Acetic Anhydride with REA...
16-Jun-2025 IOL Chemicals inches up on registering Acetic Anh...
17-May-2025 IOL Chemicals & Pharmaceuticals informs about out...
29-Apr-2025 IOL Chemicals secures approval for Ibuprofen from...
29-Apr-2025 IOL Chemicals zooms on securing approval for Ibup...
26-Mar-2025 IOL Chemicals & Pharmaceuticals informs about tra...
25-Mar-2025 IOL Chemicals commences new Unit 11 for Paracetam...
06-Mar-2025 IOL Chemicals and Pharmaceuticals gets Certificat...
13-Feb-2025 IOL Chemicals and Pharmaceuticals reports 11% fal...
02-Jan-2025 IOL Chemicals & Pharmaceuticals informs about new...
26-Nov-2024 IOL Chemicals & Pharmaceuticals informs about dis...
21-Nov-2024 IOL Chemicals and Pharmaceuticals informs about ...
28-Oct-2024 IOL Chemicals and Pharmaceuticals informs about o...
05-Oct-2024 IOL Chemicals & Pharmaceuticals informs about det...
12-Aug-2024 IOL Chemicals and Pharmaceuticals reports 35% fal...
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.